Alfacalcidol

α-骨化醇

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAlfacalcidol
Drug Alias Name1-alpha-Hydroxyvitamin D3阿法骨化醇alpha-CalcidolalfacalcidolumOxydevit +[16] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVitamin D receptor agonists
TargetsVitamin D receptor
Therapy Area/IndicationsPelvic Organ ProlapseHypothyroidismHypoparathyroidism +[14] 
Global Approved IndicationsHypoparathyroidismVitamin D DeficiencyChronic Kidney Disease-Mineral and Bone Disorder +[5] 
Approved Indications in ChinaVitamin D Deficiency
Original Approved Country/TerritoryN/A
Original Approved Date1978/01/01
Country/TerritoryPakistanEgyptIndonesia +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLeo Pharma A/S
China Registration ClassN/A

Develop Information

Active CompaniesKing Edward Medical UniversityYaopharma Co LtdLeo Pharma Inc +[5] 
Inactive CompaniesDamanhour UniversityAin Shams UniversityIndonesia University +[4] 
Active IndicationsPelvic Organ ProlapseHypothyroidismHypoparathyroidism +[10] 
Inactive IndicationsMuscle WeaknessOsteoarthritis, KneeBreast Neoplasms +[4] 

Other Information

ATC CodeA11CC03
Related LinksWikipediaDrugBankKEGG